Market Overview

UPDATE: Bank Of America Reiterates On McKesson Ahead Of 4Q14 EPS

Share:
Related MCK
12 Must Watch Stocks for July 27, 2016
Earnings Scheduled For July 27, 2016
Sometimes It Is Good to Buy the Biggest. But Should You Buy the Biggest Health Care ... (GuruFocus)

In a report published Tuesday, Bank of America analyst Robert M. Willoughby reiterated an Underperform rating on McKesson (NYSE: MCK), and raised the price target from $160.00 to $165.00.

In the report, Bank of America noted, “Rebounding profitability in MCK's core drug wholesaling operations, traction for its ancillary franchises, and capital deployment initiatives should drive industry-leading earnings growth over a leaner infrastructure. However, at valuation highs following the announcement of its Celesio acquisition, we see more attractive investment opportunities elsewhere.”

McKesson closed on Monday at $174.23.

Latest Ratings for MCK

DateFirmActionFromTo
Jul 2016CitigroupMaintainsBuy
Jul 2016Morgan StanleyMaintainsOverweight
Jun 2016BarclaysTerminatesOverweight

View More Analyst Ratings for MCK
View the Latest Analyst Ratings

Posted-In: Bank of America Robert M. WilloughbyAnalyst Color Price Target Analyst Ratings

 

Related Articles (MCK)

View Comments and Join the Discussion!